Oligoribonucucleotide For Inhibiting The Expression Of A Predefined Gene

Patent No. EP2363479 (titled "Oligoribonucucleotide For Inhibiting The Expression Of A Predefined Gene") was filed by Alnylam Europe on Jan 29, 2000. The application was issued on Jul 13, 2016.

Patent Family

Statuses, jurisdictions and citation links are shared on request.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
SILENCE THERAPEUTICS	Apr 13, 2017	STEPHEN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Feb 14, 2020
Request for change of client data cannot be registered anymore
Jan 20, 2020
Request for change of opponent's representative
Jan 20, 2020
Request for change of opponent's representative
Oct 10, 2018
Communication to the parties concerning termination of the opposition proceedings - opposition rejected - no appeal lodged
Oct 10, 2018
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Oct 5, 2018
Termination of the opposition proceedings with maintenance of patent
Jul 12, 2018
Advice of delivery
Jul 6, 2018
Advice of delivery
Jun 28, 2018
Advice of delivery
Jun 26, 2018
Advice of delivery
Jun 25, 2018
Acknowledgement of a document
Jun 25, 2018
Acknowledgement of a document
Jun 25, 2018
Decision of the Opposition Division and instruction
Jun 25, 2018
Decision rejecting the opposition
Jun 25, 2018
Grounds for the decision (Annex) - opposition
Jun 25, 2018
Internal form - Opposition/addressees
Jun 25, 2018
Scanned annex to a communication - opposition procedure
Jun 21, 2018
Notification concerning the date of oral proceedings
Jun 21, 2018
Notification concerning the date of oral proceedings
Jun 18, 2018
Written submission in preparation to/during oral proceedings
Jun 8, 2018
Brief communication - Opposition proceedings
Jun 4, 2018
(Electronic) Receipt
Jun 4, 2018
Letter accompanying subsequently filed items
Jun 4, 2018
Withdrawal of a request for oral proceedings
May 25, 2018
Brief communication - Opposition proceedings
May 17, 2018
Written submission in preparation to/during oral proceedings
May 11, 2018
Brief communication - Opposition proceedings
May 2, 2018
Patent document cited during the opposition procedure
May 2, 2018
Patent document cited during the opposition procedure
May 2, 2018
Written submission in preparation to/during oral proceedings
Apr 17, 2018
Brief communication - Opposition proceedings
Apr 10, 2018
Request for interpreters during oral proceedings
Dec 20, 2017
Advice of delivery
Dec 15, 2017
Advice of delivery
Dec 14, 2017
Advice of delivery
Dec 13, 2017
Acknowledgement of a document
Dec 13, 2017
Acknowledgement of a document
Dec 13, 2017
Annex to the communication - opposition
Dec 13, 2017
Information concerning oral proceedings
Dec 13, 2017
Summons to attend oral proceedings
Dec 13, 2017
Summons to attend oral proceedings
Dec 5, 2017
Preparation for oral proceedings
Oct 6, 2017
Brief communication - Opposition proceedings
Sep 26, 2017
Non-patent literature cited during the opposition procedure
Sep 26, 2017
Non-patent literature cited during the opposition procedure
Sep 26, 2017
Non-patent literature cited during the opposition procedure
Sep 26, 2017
Reply of the patent proprietor to the notice(s) of opposition
May 18, 2017
Communication of a notice of opposition and request to file observations
May 18, 2017
Notice of further oppositions to opponent(s)
May 16, 2017
Communication of amended entries
Apr 27, 2017
Request concerning representative opponent
Apr 20, 2017
Communication of a notice of opposition - first information to patent proprietor
Apr 13, 2017
(Electronic) Receipt
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Non-patent literature cited during the opposition procedure
Apr 13, 2017
Notice of opposition
Apr 13, 2017
Notice of opposition
Apr 13, 2017
Patent document cited during the opposition procedure
Apr 13, 2017
Patent document cited during the opposition procedure
Apr 13, 2017
Patent document cited during the opposition procedure
Jul 13, 2016
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jun 16, 2016
Decision to grant a European patent
May 25, 2016
English translation of the claims
May 25, 2016
Filing of the translations of the claims
May 25, 2016
French translation of claims
May 25, 2016
Payment of fees and costs
Jan 18, 2016
Bibliographic data of the European patent application
Jan 18, 2016
Communication about intention to grant a European patent
Jan 18, 2016
Intention to grant (signatures)
Jan 18, 2016
Text intended for grant
Nov 5, 2015
Amended claims with annotations
Nov 5, 2015
Amended description with annotations
Nov 5, 2015
Claims
Nov 5, 2015
Description
Nov 5, 2015
Reply to communication from the Examining Division
Sep 2, 2015
Annex to the communication
Sep 2, 2015
Communication from the Examining Division
Mar 12, 2015
Submission concerning representation
Jan 7, 2015
Submission concerning change of applicant's representative
Feb 19, 2014
Amended claims with annotations
Feb 19, 2014
Claims
Feb 19, 2014
Reply to communication from the Examining Division
Oct 9, 2013
Annex to the communication
Oct 9, 2013
Communication from the Examining Division
Sep 24, 2013
Examination started
Feb 23, 2012
Reply to Written Opinion prepared by the EPO
Sep 21, 2011
Refund of fees
Sep 12, 2011
Invitation to confirm maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Aug 10, 2011
Notification of forthcoming publication
Aug 8, 2011
Communication regarding the transmission of the European search report
Aug 8, 2011
European search opinion
Aug 8, 2011
European search report
Oct 29, 2010
Designation of inventor
Oct 29, 2010
Matter concerning the application
Oct 29, 2010
Non-scannable object
Oct 18, 2010
Matter concerning the application
Sep 28, 2010
Abstract
Sep 28, 2010
Claims
Sep 28, 2010
Description
Sep 28, 2010
Document related to search matters
Sep 28, 2010
Drawings
Sep 28, 2010
Request for grant of a European patent (divisional application)
Sep 28, 2010
Sequence listing
Aug 10, 2000
Priority document
Aug 10, 2000
Priority document

EP2363479

ALNYLAM EUROPE

Application Number: EP10011217A
Filing Date: Jan 29, 2000
Status: Opposition Rejected; Oct 12, 2018
Publication Date: Jul 13, 2016
External Links: Slate, Register , Google Patents

IP Verse

Oligoribonucucleotide For Inhibiting The Expression Of A Predefined Gene

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2363479